Osteoprotective Roles of Green Tea Catechins
- PMID: 33207822
- PMCID: PMC7696448
- DOI: 10.3390/antiox9111136
Osteoprotective Roles of Green Tea Catechins
Abstract
Osteoporosis is the second most common disease only secondary to cardiovascular disease, with the risk of fracture increasing with age. Osteoporosis is caused by an imbalance between osteoblastogenesis and osteoclastogenesis processes. Osteoclastogenesis may be enhanced, osteoblastogenesis may be reduced, or both may be evident. Inflammation and high reactive oxygen enhance osteoclastogenesis while reducing osteoblastogenesis by inducing osteoblast apoptosis and suppressing osteoblastic proliferation and differentiation. Catechins, the main polyphenols found in green tea with potent anti-oxidant and anti-inflammatory properties, can counteract the deleterious effects of the imbalance of osteoblastogenesis and osteoclastogenesis caused by osteoporosis. Green tea catechins can attenuate osteoclastogenesis by enhancing apoptosis of osteoclasts, hampering osteoclastogenesis, and prohibiting bone resorption in vitro. Catechin effects can be directly exerted on pre-osteoclasts/osteoclasts or indirectly exerted via the modulation of mesenchymal stem cells (MSCs)/stromal cell regulation of pre-osteoclasts through activation of the nuclear factor kB (RANK)/RANK ligand (RANKL)/osteoprotegerin (OPG) system. Catechins also can enhance osteoblastogenesis by enhancing osteogenic differentiation of MSCs and increasing osteoblastic survival, proliferation, differentiation, and mineralization. The in vitro effects of catechins on osteogenesis have been confirmed in several animal models, as well as in epidemiological observational studies on human subjects. Even though randomized control trials have not shown that catechins provide anti-fracture efficacy, safety data in the trials are promising. A large-scale, placebo-controlled, long-term randomized trial with a tea regimen intervention of optimal duration is required to determine anti-fracture efficacy.
Keywords: antioxidant; apoptosis; green tea extract; inflammation; mesenchymal stem cells; osteoprotection.
Conflict of interest statement
The authors declare that there is no conflict of interest.
Figures
References
-
- Osteoporosis Australia. [(accessed on 20 July 2020)]; Available online: http://www.osteoporosis.org.au.
-
- Tatangelo G., Watts J., Lim K., Connaughton C., Abimanyi-Ochom J., Borgstrom F., Nicholson G.C., Shore-Lorenti C., Stuart A.L., Iuliano-Burns S., et al. The Cost of Osteoporosis, Osteopenia, and Associated Fractures in Australia in 2017. J. Bone Miner. Res. 2019;34:616–625. doi: 10.1002/jbmr.3640. - DOI - PubMed
Publication types
Grants and funding
- NHRI-EX101-9935EI/National Health Research Institute
- KMUH-107-7R54/Kaohsiung Medical University Hospital
- (KMU-TC108A02-1, NCTUKMU108-BIO-04, NPUST-KMU-109-P002 and KMU-DK10500/Kaohsiung Medical University
- KMTTH107-26/Kaohsiung Municipal Ta-Tung Hospital
- MOST 108-2314-B-037 -059 -MY3/Minister of Science and Technology of Taiwan
LinkOut - more resources
Full Text Sources
